Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №8 (2024) > Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus

Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus

Konstantin V. Ovsyannikov , Evgeny A. Praskurnichiy

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Self-monitoring of blood glucose has been considered to be a cornerstone of adequate diabetes management for decades. The structured self-monitoring leads to better compensation of carbohydrate metabolism disorders, decreased risk of hypoglycemia, and quality of life improvement in patients with DM. The technologies, as well as the glucose meter convenience and accuracy have improved considerably since the moment these were introduced several decades ago. Modern glucose meters are small and easy to use; these require small amounts of capillary blood and provide measurement results within seconds. Furthermore, glucose meters are more and more often equipped with such features, as connectivity with other devices and/or electronic diaries and instruments for diabetes management. Despite the fact that the measurement accuracy can be close to or equal to the quality level ensured by laboratory biochemical analyzers, some glucose meters continue to fall short of the internationally accepted accuracy standards, such as ISO-15197, the standard of the International Organization for Standardization. Numerous reports from the number of countries, such as Russia, China, India, and Brazil, that are based on the routine practice data suggest that in addition to the problems with the glucose meter accuracy, there are other obstacles to overcome to optimize the use of blood glucose monitoring systems. Nevertheless, the adequate use of blood glucose self-monitoring data is very important for treatment of patients with type 2 diabetes mellitus.
Keywords: self-monitoring of blood glucose, type 2 diabetes mellitus, blood glucose monitoring systems, accuracy, diabetes management, glucose meters.

About the Author

Konstantin V. Ovsyannikov 1 , Evgeny A. Praskurnichiy 2

1 Burnazyan Federal Medical Biophysical Center of the FMBA of Russia, Moscow, Russia; Clinical Hospital No85, Moscow, Russia

2 Burnazyan Federal Medical Biophysical Center of the FMBA of Russia, Moscow, Russia

References

1. International Diabetes Federation. IDF diabetes atlas 10th edition, 2021.
URL: https://diabetesatlas.org/data/en/ (Access date 06.09.2024)
2. Diabetes Control and Complications Trial Research Group. Nathan
DM, Genuth S et al. The effect of intensive treatment of diabetes on the
development and progression of long-term complications in insulin-de-
pendent diabetes mellitus. N Engl J Med 1993;329:977-86. DOI:
10.1056/nejm199309303291401
3. American Diabetes Association. Standards of medical care in diabetes –
2021. Diabetes Care 2021;44(Suppl 1). DOI: 10.2337/dc21-SINT.
4. Mannucci E, Antenore A, Giorgino F, Scavini M. Effects of structured
versus unstructured self-monitoring of blood glucose on glucose cont-
rol in patients with non-insulin-treated type 2 diabetes: a meta-analysis
of randomized controlled trials. J Diabetes Sci Technol 2018;12:183-9.
DOI: 10.1177/1932296817719290
5. Schnell O, Alawi H, Battelino T et al. Self-monitoring of blood glucose
in type 2 diabetes: recent studies. J Diabetes Sci Technol 2013;7:478-
88. DOI: 10.1177/193229681300700225
6. Malanda UL, Welschen LM, Riphagen II et al. Self-monitoring of
blood glucose in patients with type 2 diabetes mellitus who are not
using insulin. Cochrane Database Syst Rev 2012;1:Cd005060. DOI:
10.1002/14651858.CD005060.pub3
7. Farmer AJ, Perera R, Ward A et al. Meta-analysis of individual patient data
in randomised trials of self-monitoring of blood glucose in people with non-
insulin treated type 2 diabetes. BMJ 2012;344:e486. DOI: 10.1136/bmj.e486
8. O’Kane MJ, Bunting B, Copeland M, Coates VE. Efficacy of self-moni-
toring of blood glucose in patients with newly diagnosed type 2 diabetes
(ESMON study): randomised controlled trial. BMJ 2008;336:1174-77.
DOI: 10.1136/bmj.39534.571644.BE
9. Polonsky WH, Fisher L, Schikman CH et al. Structured self-monitoring
of blood glucose significantly reduces A1C levels in poorly controlled,
noninsulin-treated type 2 diabetes: results from the Structured Testing
Program study. Diabetes Care 2011;34:262-7. DOI: 10.2337/dc10-1732
10. Schnell O, Alawi H, Battelino T et al. Addressing schemes of self-moni-
toring of blood glucose in type 2 diabetes: a European perspective and
expert recommendation. Diabetes Technol Ther 2011;13:959-65. DOI:
10.1089/dia.2011.0028
11. Freckmann G. Basics and use of continuous glucose monitoring (CGM) in dia-
betes therapy. J Lab Med 2020;44:71-9. DOI: 10.1515/labmed-2019-0189
12. Dicembrini I, Cosentino C, Monami M et al. Effects of real-time conti-
nuous glucose monitoring in type 1 diabetes: a meta-analysis of rando-
mized controlled trials. Acta Diabetol 2021;58:401-10. DOI:
10.1007/s00592-020-01589-3
13. Slattery D, Choudhary P. Clinical use of continuous glucose monitoring
in adults with type 1 diabetes. Diabetes Technol Ther 2017;19:S55-61.
DOI: 10.1089/dia.2017.0051
14. Janapala RN, Jayaraj JS, Fathima N et al. Continuous glucose monito-
ring versus self-monitoring of blood glucose in type 2 diabetes mellitus:
a systematic review with meta-analysis. Cureus 2019;11:e5634. DOI:
10.7759/cureus.5634 
15. Lin R, Brown F, James S, Jones J, Ekinci E. Continuous glucose moni-
toring: A review of the evidence in type 1 and 2 diabetes mellitus. Dia-
bet Med 2021;38:e14528. DOI: 10.1111/dme.14528
16. Freckmann G, Pleus S, Grady M et al. Measures of accuracy for conti-
nuous glucose monitoring and blood glucose monitoring devices. J Dia-
betes Sci Technol 2019;13:575-83.DOI: 10.1177/1932296818812062
17. Freckmann G, Nichols JH, Hinzmann R et al. Standardization process
of continuous glucose monitoring: Traceability and performance. Clin
Chim Acta 2021;515:5-12. DOI: 10.1016/j.cca.2020.12.025
18. Skyler JS, Lasky IA, Skyler DL et al. Home blood glucose monitoring as
an aid in diabetes management. Diabetes Care 1978;1:150-7. DOI:
10.2337/diacare.1.3.150
19. Freckmann G, Jendrike N, Baumstark A et al. User performance eva-
luation of four blood glucose monitoring systems applying ISO
15197:2013 accuracy criteria and calculation of insulin dosing errors.
Diabetes Ther 2018;9:683-97. DOI: 10.1007/s13300-018-0392-6
20. Breton MD, Kovatchev BP. Impact of blood glucose self-monitoring er-
rors on glucose variability, risk for hypoglycemia, and average glucose
control in type 1 diabetes: an in silico study. J Diabetes Sci Technol
2010;4:562-70. DOI: 10.1177/193229681000400309
21. International Organization for Standardization. In vitro diagnostic test
systems−requirements for blood-glucose monitoring systems for self-
testing in managing diabetes mellitus (ISO 15197:2013). Geneva: Inter-
national Organization for Standardization, 2015.
22. US Food and Drug Administration. Self-monitoring blood glucose test sy-
stems for over-the-counter use—guidance for industry and food and drug
administration staff. 2020. URL: https://www.fda.gov/regulatory-infor-
mation/search-fda-guidance-documents/self-monitoring-blood-glucose-
test-systems-over-counter-use. (Access date 06.09. 2024)
23. King F, Ahn D, Hsiao V et al. A review of blood glucose monitor accu-
racy. Diabetes Technol Ther 2018;20:843-56. DOI: 10.1089/dia.2018.
0232
24. Klonoff DC, Parkes JL, Kovatchev BP et al. Investigation of the accuracy
of 18 marketed blood glucose monitors. Diabetes Care 2018;41:1681-8.
DOI: 10.2337/dc17-1960
25. Diabetes Technology Society. Blood glucose monitoring system surveil-
lance program. 2017. URL: https://www.diabetestechnology.org/sur-
veillance.shtml. (Access date 06.09.2024)
26. Ginsberg BH. Factors affecting blood glucose monitoring: sources of er-
rors in measurement. J Diabetes Sci Technol 2009;3:903-13. DOI:
10.1177/193229680900300438 
27 CLSI. Interference Testing in Clinical Chemistry. 3rd ed. CLSI guideline
EP07. Wayne, PA: Clinical and Laboratory Standards Institute, 2018.
28. Giavarina D. Understanding Bland Altman analysis. Biochem Med (Za-
greb) 2015;25:141-51. DOI: 10.11613/BM.2015.015
29. Carpenter R, Dichiacchio T, Barker K. Interventions for self-manage-
ment of type 2 diabetes: an integrative review. Int J Nurs Sci
2018;6(1):70-91. 10.1016/j.ijnss.2018.12.002
30. Jimenez G, Lum E, Huang Z et al. Reminders for medication adherence
in Type 2 diabetes management apps. J Pharm Pract Res 2020;50:78-
81. DOI: 10.1002/jppr.1595
31. Pantalone KM, Misra-Hebert AD, Hobbs TM et al. Clinical inertia in
type 2 diabetes management: evidence from a large, real-world data
set. Diabetes Care 2018;41:e113-e114. DOI: 10.2337/dc18-0116
32. Schmidt S, Nørgaard K. Bolus calculators. J Diabetes Sci Technol
2014;8:1035-41. DOI: 10.1177/1932296814532906 
33. Parkin CG, Davidson JA. Value of self-monitoring blood glucose pa-
ttern analysis in improving diabetes outcomes. J Diabetes Sci Technol
2009;3:500-8. DOI: 10.1177/193229680900300314
34. Kulzer B, Daenschel W, Daenschel I et al. Integrated personalized dia-
betes management improves glycemic control in patients with insulin-
treated type 2 diabetes: results of the PDM-ProValue study program.
Diabetes Res Clin Pract 2018;144:200-12. DOI: 10.1016/j.dia-
bres.2018.09.002
35. Contreras I, Vehi J. Artificial intelligence for diabetes management and
decision support: literature review. J Med Internet Res
2018;20:e10775. DOI: 10.2196/10775
36. Guo XH, Yuan L, Lou QQ et al. A nationwide survey of diabetes educa-
tion, self-management and glycemic control in patients with type 2 dia-
betes in China. Chin Med J 2012;125:4175-80 
37. Wang X, Luo J-F, Qi L et al. Adherence to self-monitoring of blood glu-
cose in Chinese patients with type 2 diabetes: current status and influ-
ential factors based on electronic questionnaires. Patient Prefer Adher
2019;13:1269-82. DOI: 10.2147/PPA.S211668 
38. Yao J, Wang H, Yan J et al. Understanding the profiles of blood glucose
monitoring among patients with type 2 diabetes mellitus: a cross-sec-
tional study in Shandong. China Patient Prefer Adher 2021;15:399-
409. DOI: 10.2147/ppa.s292086
39. Ji L, Su Q, Feng B, et al. Glycemic control and self-monitoring of blood
glucose in Chinese patients with type 2 diabetes on insulin: baseline re-
sults from the COMPASS study. Diabetes Res Clin Pract 2016;112:82-
7. DOI: 10.1016/j.diabres.2015.08.005
40. Yao J, Wang H, Yin X et al. The association between self-efficacy and
self-management behaviors among Chinese patients with type 2 diabe-
tes. PLoS ONE 2019;14:e0224869-e. DOI: 10.1371/journal.pone.
0224869
41. Zhang L, He X, Shen Y et al. Effectiveness of smartphone app-based in-
teractive management on glycemic control in Chinese patients with po-
orly controlled diabetes: randomized controlled trial. J Med Internet
Res 2019;21:e15401. DOI: 10.2196/15401
42. Rao PV, Makkar BM, Kumar A et al. RSSDI consensus on self-monitoring
of blood glucose in types 1 and 2 diabetes mellitus in India. Int J Diabetes
Dev Ctries 2018;38:260-79. DOI: 10.1007/s13410-018-0677-3
43. Verma M, Junaid A, Verma K, Das Gupta D. Exploring the role of social
media as a support mechanism among persons with diabetes: an online
ethnographic study. J Content Community Commun 2019;10:78-85.
DOI: 10.31620/JCCC.12.19/09.
44. Chittem M, Sridharan SG, Pongener M et al. Experiences of barriers to
self-monitoring and medication-management among Indian patients
with type 2 diabetes, their primary family-members and physicians.
Chronic Illn 2021. DOI: 10.1177/17423953211032251
45. Hissa MN. Brazilian multicenter study for the evaluation of patients’
satisfaction of blood glucose self-monitoring with BGStar(®) blood
glucose meter in insulinized patients with diabetes mellitus type 1 and
2. Diabetol Metab Syndr 2016;8:66. DOI: 10.1186/s13098-016-0180-2
46. Viana LV, Leitão CB, Grillo Mde F et al. Are diabetes management gui-
delines applicable in ’real life’? Diabetol Metab Syndr 2012;4:47. DOI:
10.1186/1758-5996-4-47
47. Silva DD, Bosco AA. An educational program for insulin self-adjust-
ment associated with structured self-monitoring of blood glucose signi-
ficantly improves glycemic control in patients with type 2 diabetes mel-
litus after 12 weeks: a randomized, controlled pilot study. Diabetol Me-
tab Syndr 2015;7:2. DOI: 10.1186/1758-5996-7-2
48. Caswell M. et al: Accuracy and User Performance Evaluation of a Blood
Glucose Monitoring System. Diabetes Technol Ther 2015;3:152 - 8
49. S. Pleus et al.Performance of two updated blood glucose monitoring sys-
tems: an evaluation following ISO 15197:2013.Current Medical Re-
search and Opinion . 2016; 32,5:847-855
50. Bailey T. et al. Accuracy and User Performance Evaluation of a New,
Wireless-enabled Blood Glucose Monitoring System That Links to a
Smart Mobile Device. Journal of Diabetes Science and Technology.
2017; Vol. 11(4):736-743

For citation:Ovsyannikov K.V., Praskurnichiy E.A. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus. Clinical review for general practice. 2024; 5 (8): 116–124 (In Russ.). DOI: 10.47407/kr2024.5.8.00469


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru